New Phase 3 Data on Icotrokinra Suggest Efficacy for Genital, Scalp Psoriasis
These data from the ICONIC-TOTAL trial program highlight icotrokinra’s use as a selective IL-23 inhibitor and its effectiveness in skin clearance for psoriasis.
Related Articles
Skin of Color Savvy: HS Management in Skin of Color, with Tiffany Mayo, MD, Steven Daveluy, MD, Jasmine Ivanna Espy
This episode of the SOCS podcast features an in-depth discussion between Tiffany Mayo, MD, Steven Daveluy, MD, and patient advocate Jasmine Ivanna Espy.
Study Finds Underuse of Allergy Treatments in Teens with Pollen Allergic Rhinitis
A study shows that many children with pollen allergies face ongoing symptoms into adulthood, highlighting the need for better management.
Diabetes Dialogue: Tirzepatide vs Semaglutide for Obesity, Understanding SURMOUNT-5
Discover the latest findings on tirzepatide vs semaglutide for obesity treatment, highlighting significant weight loss results & clinical insights.
Clinical Perspectives in IBD: An IL-23 Inhibitor with Head-to-Head Results in an Open-Label Crohn’s Disease Study – GI Therapies HCP Live
Evaluate efficacy and show safety results of Risankizumab vs Ustekinumab for the treatment of moderate-to-severe Crohn’s Disease. Explore the study design and outcomes of Risankizumab’s…
Skin of Color Savvy: HS Management in Skin of Color, with Tiffany Mayo, MD, Steven Daveluy, MD, Jasmine Ivanna Espy
This episode of the SOCS podcast features an in-depth discussion between Tiffany Mayo, MD, Steven Daveluy, MD, and patient advocate Jasmine Ivanna Espy.
IgA Nephropathy
The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and…
Study Finds Distinct Brain Changes in Sleep Disorders vs Sleep Deprivation
New research uncovers unique brain abnormalities linked to sleep disorders and deprivation, revealing insights into emotional and cognitive impacts.
Unmet Needs in Atopic Dermatitis and the Impact of Roflumilast Cream, with Raj Chovatiya, MD, PhD
In this interview, Raj Chovatiya, MD, PhD, describes roflumilast cream’s success in addressing unmet needs for atopic dermatitis.
Global Rates of Gout Rising in Young Adults
Adolescent gout rates are rising globally, highlighting the need for early intervention and lifestyle changes to mitigate health risks.
UBX1325 Matches Aflibercept in Vision Gains for DME at 36 Weeks
UBX1325 exhibited noninferiority to aflibercept in difficult-to-treat diabetic macular edema, while maintaining a favorable safety profile in the ASPIRE study.